This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: The Innovations of Jing Ren
Introduction
Jing Ren is a notable inventor based in Lianyungang, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative compounds for medical use. His work focuses on addressing BTK-related diseases, showcasing his commitment to advancing healthcare solutions.
Latest Patents
Jing Ren holds a patent for a furo[3,4-b]pyrrole-containing BTK inhibitor. This invention pertains to a compound that has potential applications in treating various BTK-related diseases. The patent includes details on the compound's formula, its stereoisomers, pharmacologically acceptable salts, preparation methods, and pharmaceutical compositions.
Career Highlights
Jing Ren is associated with Chia Tai Tianqing Pharmaceutical Group Co., Ltd., where he continues to contribute to pharmaceutical innovations. His expertise in pharmaceutical chemistry has positioned him as a valuable asset in the industry.
Collaborations
Jing Ren has collaborated with notable colleagues, including Yinsheng Zhang and Hongjiang Xu. These partnerships enhance the research and development efforts within their organization.
Conclusion
Jing Ren's work exemplifies the impact of innovative thinking in pharmaceutical chemistry. His contributions, particularly in developing BTK inhibitors, highlight the importance of research in improving medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile